GENE ONLINE|News &
Opinion
Blog

Precision Medicine
With Precision Health its new focus, Taiwan Shines at BIO 2022 Global Innovation HUB Presentations
2022-07-23
APCM 2022: Precision Medicine Is Opening Up a New Prospect of Cancer Therapy
2022-05-04Partner
Acrivon Therapeutics to Advance Proteomics Platform & Oncology Pipeline with $100M Series B Financing
2021-11-12
Can Regulations Measure up to the Progress of Precision Medicine in Taiwan? – An Interview With Dr. Johnsee Lee
2021-10-30
Revealing the Underestimated Potential of Natural RNA Editing – An Interview with Dr. Trees-Juen Chuang
2021-09-17
The Defining Role of Metabolism in Human Health and Disease
2021-08-12
The Future of Precision Medicine: From Gene Therapy to Data Sharing Boom – Excerpts from the US-Taiwan Precision Medicine Forum
2021-07-21Partner
#ASCO21: Large Cohort Study by Foundation Medicine and Collaborators Reveal Disparities in Precision Cancer Care
2021-06-09
R&D
Mirvie Heralds Liquid Biopsy-Based Test to Predict Pregnancy Complications
2021-04-28
Singapore Targets Widespread Implementation of Precision Medicine, Launches Phase II of its 10-Year Plan
2021-04-10
How Can Organoid and Mouse Models Boost Oncology Preclinical Trials? – Highlights from the Crown Biosciences Symposium
2021-03-10Partner
Taiwan Kicks off 2020 Healthcare Expo, Targeting Strategies to Boost Digital Transformation in Biopharma Industry
2020-12-03
Prometheus Bags $130 Million to Develop Precision Medicines for IBD Treatment
2020-11-10
Advance Precision Medicine by Applying Circulating Tumor Cells for Anti-Cancer Drug Screen
2020-10-20Partner
Top Highlights of BIO Asia-Taiwan 2020
2020-07-29Partner
1 2 3
LATEST
A New Sequencer on the Horizon – Illumina Genomics Forum Days Two and Three Highlights
2022-09-30
Novo Nordisk Places $700 Million Bet on Ventus’ NLRP3 Inhibitor Program
2022-09-30
Amylyx’s ALS Drug Nabs FDA Nod After Rare Regulatory Reversal
2022-09-29
Illumina Reveals NovaSeq™ X Series at the Illumina Genomics Forum
2022-09-29
Illumina Genomics Forum Kicks Off With A Conversation With President Barack Obama
2022-09-29
First Patient in New Zealand Dosed with Illuccix® – Telix's Prostate Cancer Imaging Agent
2022-09-29
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022
2022-09-29
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!